The leukemia therapeutics market reached a substantial valuation of USD 16.63 billion in 2024, with the market projected to grow from USD 17.68 billion in 2025 to an impressive USD 31.43 billion by 2034, exhibiting a robust compound annual growth rate of 6.6% throughout the forecast period. This significant expansion trajectory reflects advancing treatment modalities, increasing diagnostic...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek